Female reproductive functions of the neuropeptide PACAP
暂无分享,去创建一个
[1] Xinjie Liu,et al. CGRP and PACAP-38 play an important role in diagnosing pediatric migraine , 2022, The Journal of Headache and Pain.
[2] E. J. Wagner,et al. The PACAP Paradox: Dynamic and Surprisingly Pleiotropic Actions in the Central Regulation of Energy Homeostasis , 2022, Frontiers in Endocrinology.
[3] Severin T. Schneebeli,et al. GPCR Intracellular Loop Regulation of Beta-Arrestin-Mediated Endosomal Signaling Dynamics , 2022, Journal of Molecular Neuroscience.
[4] M. Bujak,et al. Expression of Oxidative Stress and Inflammation-Related Genes in Nasal Mucosa and Nasal Polyps from Patients with Chronic Rhinosinusitis , 2022, International journal of molecular sciences.
[5] J. Całka,et al. Investigation of the Role of Pituitary Adenylate Cyclase-Activating Peptide (PACAP) and Its Type 1 (PAC1) Receptor in Uterine Contractility during Endometritis in Pigs , 2022, International journal of molecular sciences.
[6] D. Reglodi,et al. Effects of Pituitary Adenylate Cyclase Activating Polypeptide on Cell Death , 2022, International journal of molecular sciences.
[7] A. Castorina,et al. Exploring the Pro-Phagocytic and Anti-Inflammatory Functions of PACAP and VIP in Microglia: Implications for Multiple Sclerosis , 2022, International journal of molecular sciences.
[8] P. Ferdinandy,et al. PACAP-38 and PAC1 Receptor Alterations in Plasma and Cardiac Tissue Samples of Heart Failure Patients , 2022, International journal of molecular sciences.
[9] Yingying Han,et al. Seasonal changes in the expression of PACAP, VPAC1, VPAC2, PAC1 and testicular activity in the testis of the muskrat (Ondatra zibethicus) , 2022, European journal of histochemistry : EJH.
[10] G. Stuber,et al. PACAP‐expressing neurons in the lateral habenula diminish negative emotional valence , 2022, Genes, brain, and behavior.
[11] Daniel Pham,et al. Examination of pituitary adenylate cyclase-activating polypeptide in Parkinson’s disease focusing on correlations with motor symptoms , 2022, GeroScience.
[12] G. Musumeci,et al. PACAP and VIP Mitigate Rotenone-Induced Inflammation in BV-2 Microglial Cells , 2022, Journal of Molecular Neuroscience.
[13] D. Latek,et al. Signal Transduction by VIP and PACAP Receptors , 2022, Biomedicines.
[14] D. Zaia,et al. Arcuate nucleus of the hypothalamus contributes to the hypophagic effect and plasma metabolic changes induced by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide , 2022, Neurochemistry International.
[15] M. Ashina,et al. Calcitonin gene-related peptide and pituitary adenylate cyclase-activating polypeptide in migraine treatment , 2022, Current opinion in endocrinology, diabetes, and obesity.
[16] Fang-hong Chen,et al. Pituitary adenylate cyclase-activating polypeptide receptor activation in the hypothalamus recruits unique signaling pathways involved in energy homeostasis. , 2022, American journal of physiology. Endocrinology and metabolism.
[17] T. Hirabayashi,et al. Potential Therapeutic Role of Pituitary Adenylate Cyclase-Activating Polypeptide for Dry Eye Disease , 2022, International journal of molecular sciences.
[18] M. Togha,et al. Evaluation of Serum Levels of Transient Receptor Potential Cation Channel Subfamily V Member 1, Vasoactive Intestinal Polypeptide, and Pituitary Adenylate Cyclase-Activating Polypeptide in Chronic and Episodic Migraine: The Possible Role in Migraine Transformation , 2021, Frontiers in Neurology.
[19] K. Lutfy,et al. The PACAP/PAC1 Receptor System and Feeding , 2021, Brain sciences.
[20] V. May,et al. Activation of Lateral Parabrachial Nucleus (LPBn) PACAP-Expressing Projection Neurons to the Bed Nucleus of the Stria Terminalis (BNST) Enhances Anxiety-like Behavior , 2021, Journal of Molecular Neuroscience.
[21] C. Saper,et al. Genetic identification of preoptic neurons that regulate body temperature in mice , 2021, Temperature.
[22] Zhenxiang Zhao,et al. Correlation of Decreased Serum Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Levels With Non-motor Symptoms in Patients With Parkinson’s Disease , 2021, Frontiers in Aging Neuroscience.
[23] A. Tamas,et al. Changes of pituitary adenylate cyclase activating polypeptide (PACAP) level in polytrauma patients in the early post-traumatic period , 2021, Peptides.
[24] J. Yamashita,et al. Estrogen mediates sex differences in preoptic neuropeptide and pituitary hormone production in medaka , 2021, Communications biology.
[25] K. Palus,et al. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Physiological and Pathological Processes within the Gastrointestinal Tract: A Review , 2021, International journal of molecular sciences.
[26] G. Toth,et al. Retinoprotective Effects of PACAP Eye Drops in Microbead-Induced Glaucoma Model in Rats , 2021, International journal of molecular sciences.
[27] D. Reglodi,et al. Multimodal Role of PACAP in Glioblastoma , 2021, Brain sciences.
[28] Li Guo,et al. Pituitary Adenylate Cyclase-Activating Polypeptide Protects Against Cognitive Impairment Caused by Chronic Cerebral Hypoperfusion , 2021, Molecular Neurobiology.
[29] Rubens Wajnsztejn,et al. Kisspeptin Levels in Girls with Precocious Puberty: A Systematic Review and Meta-Analysis , 2021, Hormone Research in Paediatrics.
[30] V. May,et al. PAC1 Receptor Internalization and Endosomal MEK/ERK Activation Is Essential for PACAP-Mediated Neuronal Excitability , 2021, Journal of Molecular Neuroscience.
[31] E. J. Wagner,et al. Adaptive Changes in the Central Control of Energy Homeostasis Occur in Response to Variations in Energy Status , 2021, International journal of molecular sciences.
[32] J. Leprince,et al. Intranasal Administration of PACAP Is an Efficient Delivery Route to Reduce Infarct Volume and Promote Functional Recovery After Transient and Permanent Middle Cerebral Artery Occlusion , 2021, Frontiers in Endocrinology.
[33] R. Jensen,et al. The G Protein–Coupled Receptor PAC1 Regulates Transactivation of the Receptor Tyrosine Kinase HER3 , 2020, Journal of Molecular Neuroscience.
[34] T. Hirabayashi,et al. Attenuation of Relaxing Response Induced by Pituitary Adenylate Cyclase-Activating Polypeptide in Bronchial Smooth Muscle of Experimental Asthma. , 2020, American journal of physiology. Lung cellular and molecular physiology.
[35] B. Buyukaydin,et al. Prevention and Treatment , 2020, Orthostatic Hypotension in Older Adults.
[36] C. Musio,et al. ClC-2-like Chloride Current Alterations in a Cell Model of Spinal and Bulbar Muscular Atrophy, a Polyglutamine Disease , 2020, Journal of molecular neuroscience : MN.
[37] A. Tamas,et al. Investigation of pituitary adenylate cyclase activating polypeptide (PACAP) in human amniotic fluid samples. , 2020, Reproductive biology.
[38] Carolina Q. Sacramento,et al. VIP plasma levels associate with survival in severe COVID‐19 patients, correlating with protective effects in SARS‐CoV‐2‐infected cells , 2020, bioRxiv.
[39] D. Vaudry,et al. Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Against Cognitive Decline in Neurodegenerative Diseases , 2020, Frontiers in Cellular Neuroscience.
[40] A. Tamas,et al. Protective Effects of PACAP in Peripheral Organs , 2020, Frontiers in Endocrinology.
[41] O. Kántor,et al. Current State of Understanding of the Role of PACAP in the Hypothalamo-Hypophyseal Gonadotropin Functions of Mammals , 2020, Frontiers in Endocrinology.
[42] A. Tamas,et al. Pituitary adenylate cyclase activating polypeptide concentrations in the sheep mammary gland, milk, and in the lamb blood plasma after suckling. , 2020, Physiology international.
[43] A. Tamas,et al. Possible effects of pituitary adenylate cyclase activating polypeptide (PACAP) on early embryo implantation marker HB-EGF in mouse. , 2020, Reproductive biology.
[44] M. Mollica,et al. Pituitary Adenylate Cyclase-Activating Peptide (PACAP) and its receptors in Mus musculus testis. , 2020, General and comparative endocrinology.
[45] M. Gillette,et al. Pituitary Adenylate Cyclase-Activating Peptide (PACAP)-Glutamate Co-transmission Drives Circadian Phase-Advancing Responses to Intrinsically Photosensitive Retinal Ganglion Cell Projections by Suprachiasmatic Nucleus , 2019, Front. Neurosci..
[46] L. Ciranna,et al. Pituitary Adenylate Cyclase-Activating Polypeptide Modulates Hippocampal Synaptic Transmission and Plasticity: New Therapeutic Suggestions for Fragile X Syndrome , 2019, Front. Cell. Neurosci..
[47] D. Reglodi,et al. Phenotypic characterization of testicular immune cells expressing immune checkpoint molecules in wild‐type and pituitary adenylate cyclase‐activating polypeptide‐deficient mice , 2019, American journal of reproductive immunology.
[48] A. S. Laganà,et al. The role of Kisspeptin levels in polycystic ovary syndrome: a systematic review and meta-analysis , 2019, Archives of Gynecology and Obstetrics.
[49] J. Całka,et al. Endometritis affects chemical coding of the dorsal root ganglia neurons supplying uterus in the sexually mature gilts. , 2019, Research in veterinary science.
[50] Bing-Yin Sun,et al. Decreased synovial fluid pituitary adenylate cyclase-activating polypeptide (PACAP) levels may reflect disease severity in post-traumatic knee osteoarthritis after anterior cruciate ligament injury , 2019, Peptides.
[51] A. Tamas,et al. VPAC1 receptors play a dominant role in PACAP-induced vasorelaxation in female mice , 2019, PloS one.
[52] M. Oláh,et al. Intranasal application of PACAP and β-cyclodextrin before the “critical period of proestrous stage” can block ovulation , 2019, Biologia futura.
[53] S. Kyo,et al. Effect of pituitary adenylate cyclase-activating polypeptide (PACAP) in the regulation of hypothalamic kisspeptin expression. , 2019, General and comparative endocrinology.
[54] S. Kyo,et al. Role of kisspeptin and Kiss1R in the regulation of prolactin gene expression in rat somatolactotroph GH3 cells , 2018, Endocrine.
[55] D. Reglodi,et al. Comparative analysis of decidual and peripheral immune cells and immune‐checkpoint molecules during pregnancy in wild‐type and PACAP‐deficient mice , 2018, American journal of reproductive immunology.
[56] V. May,et al. PACAP-Induced PAC1 Receptor Internalization and Recruitment of Endosomal Signaling Regulate Cardiac Neuron Excitability , 2018, Journal of Molecular Neuroscience.
[57] R. Casadonte,et al. Accelerated pre‐senile systemic amyloidosis in PACAP knockout mice – a protective role of PACAP in age‐related degenerative processes , 2018, The Journal of pathology.
[58] S. Kyo,et al. Role of pituitary adenylate cyclase‐activating polypeptide in modulating hypothalamic‐pituitary system , 2018, Reproductive medicine and biology.
[59] B. Lowell,et al. PACAP neurons in the ventral premammillary nucleus regulate reproductive function in the female mouse , 2018, bioRxiv.
[60] R. Zákány,et al. Disturbed spermatogenic signaling in pituitary adenylate cyclase activating polypeptide-deficient mice. , 2018, Reproduction.
[61] A. Tamas,et al. Examination of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) as a Potential Biomarker in Heart Failure Patients , 2018, Journal of Molecular Neuroscience.
[62] Alison Twycross,et al. What is a case study? , 2017, Evidence Based Journals.
[63] S. Kyo,et al. Interaction between kisspeptin and adenylate cyclase-activating polypeptide 1 on the expression of pituitary gonadotropin subunits: a study using mouse pituitary lbetaT2 cells† , 2017, Biology of Reproduction.
[64] Ingela Lanekoff,et al. PACAP suppresses dry eye signs by stimulating tear secretion , 2016, Nature Communications.
[65] S. Kyo,et al. Expression and Regulation of Pituitary Adenylate Cyclase-Activating Polypeptide in Rat Placental Cells , 2016, Reproductive Sciences.
[66] A. Buki,et al. Changes of PACAP level in cerebrospinal fluid and plasma of patients with severe traumatic brain injury , 2014, Peptides.
[67] A. Tamas,et al. Characterization of the Thermoregulatory Response to Pituitary Adenylate Cyclase-Activating Polypeptide in Rodents , 2014, Journal of Molecular Neuroscience.
[68] M. Cohen,et al. Investigation of the Possible Functions of PACAP in Human Trophoblast Cells , 2014, Journal of Molecular Neuroscience.
[69] A. Tamas,et al. Comparative Protein Composition of the Brains of PACAP-Deficient Mice Using Mass Spectrometry-Based Proteomic Analysis , 2014, Journal of Molecular Neuroscience.
[70] A. Tamas,et al. Influence of Terminal Differentiation and PACAP on the Cytokine, Chemokine, and Growth Factor Secretion of Mammary Epithelial Cells , 2013, Journal of Molecular Neuroscience.
[71] A. Tamas,et al. Examination of PACAP38-like immunoreactivity in different milk and infant formula samples. , 2013, Acta physiologica Hungarica.
[72] H. Kanasaki,et al. Possible Role of PACAP and Its PAC1 Receptor in the Differential Regulation of Pituitary LHbeta- and FSHbeta-Subunit Gene Expression by Pulsatile GnRH Stimulation1 , 2013, Biology of reproduction.
[73] T. Griffith,et al. Therapeutic potential of VIP vs PACAP in diabetes. , 2012, Journal of molecular endocrinology.
[74] A. Tamas,et al. Role of PACAP in Female Fertility and Reproduction at Gonadal Level – Recent Advances , 2012, Front. Endocrin..
[75] A. Tamas,et al. Effects of Pituitary Adenylate Cyclase Activating Polypeptide on Human Sperm Motility , 2012, Journal of Molecular Neuroscience.
[76] A. Tamas,et al. Changes in PACAP Immunoreactivity in Human Milk and Presence of PAC1 Receptor in Mammary Gland during Lactation , 2012, Journal of Molecular Neuroscience.
[77] A. Lakatos,et al. PACAP is an Endogenous Protective Factor—Insights from PACAP-Deficient Mice , 2012, Journal of Molecular Neuroscience.
[78] H. Vaudry,et al. Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide. , 2012, Biochimica et biophysica acta.
[79] A. Tamas,et al. Correlation Between Oocyte Number and Follicular Fluid Concentration of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Women After Superovulation Treatment , 2012, Journal of Molecular Neuroscience.
[80] A. Tamas,et al. Presence of pituitary adenylate cyclase-activating polypeptide (PACAP) in the plasma and milk of ruminant animals. , 2011, General and comparative endocrinology.
[81] A. Tamas,et al. Investigation of pituitary adenylate cyclase activating polypeptide in human gynecological and other biological fluids by using MALDI TOF mass spectrometry. , 2011, Journal of mass spectrometry : JMS.
[82] A. Tamas,et al. Alterations of pituitary adenylate cyclase-activating polypeptide-like immunoreactivity in the human plasma during pregnancy and after birth , 2010, Journal of endocrinological investigation.
[83] A. Tamas,et al. Changes in the Expression of Pituitary Adenylate Cyclase-Activating Polypeptide in the Human Placenta during Pregnancy and Its Effects on the Survival of JAR Choriocarcinoma Cells , 2010, Journal of Molecular Neuroscience.
[84] M. Tohyama,et al. Increased Stathmin1 Expression in the Dentate Gyrus of Mice Causes Abnormal Axonal Arborizations , 2010, Neuroscience Research.
[85] R. Hokao,et al. The different effects of i.c.v. injection of pituitary adenylate cyclase activating polypeptide (PACAP) on prolactin secretion in adult male and lactating rats. , 2009, Experimental animals.
[86] H. Vaudry,et al. Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery , 2009, Pharmacological Reviews.
[87] H. Vaudry,et al. Distribution and functional characterization of pituitary adenylate cyclase–activating polypeptide receptors in the brain of non-human primates , 2009, Neuroscience.
[88] A. Tamas,et al. Presence of pituitary adenylate cyclase activating polypeptide-38 in human plasma and milk. , 2009, European journal of endocrinology.
[89] A. Lakatos,et al. Effects of Pituitary Adenylate Cyclase Activating Polypeptide on the Survival and Signal Transduction Pathways in Human Choriocarcinoma Cells , 2009, Annals of the New York Academy of Sciences.
[90] T. Iwanaga,et al. Suppressive action of pituitary adenylate cyclase activating polypeptide (PACAP) on proliferation of immature mouse Leydig cell line TM3 cells. , 2008, Biomedical research.
[91] H. Hashimoto,et al. PACAP is transiently expressed in anterior pituitary gland of rats: In situ hybridization and cell immunoblot assay studies , 2008, Peptides.
[92] N. Sherwood,et al. Pituitary adenylate cyclase-activating polypeptide (PACAP) is important for embryo implantation in mice , 2008, Molecular and Cellular Endocrinology.
[93] S. Shioda,et al. Localization, characterization and function of pituitary adenylate cyclase-activating polypeptide during brain development , 2007, Peptides.
[94] J. Laverrière,et al. What is the role of PACAP in gonadotrope function? , 2007, Peptides.
[95] V. Batuman,et al. Intravenous infusion of pituitary adenylate cyclase-activating polypeptide (PACAP) in a patient with multiple myeloma and myeloma kidney: A case study , 2007, Peptides.
[96] M. Stefanini,et al. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary. , 2007, Reproduction.
[97] E. Diamandis,et al. Proteomics Analysis of Human Amniotic Fluid *S , 2007, Molecular & Cellular Proteomics.
[98] Z. Szilvássy,et al. Changes of PACAP levels in the brain show gender differences following short-term water and food deprivation. , 2007, General and comparative endocrinology.
[99] J. Olesen,et al. The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers , 2007, Regulatory Peptides.
[100] K. Sayasith,et al. Gonadotropin-dependent regulation of bovine pituitary adenylate cyclase-activating polypeptide in ovarian follicles prior to ovulation. , 2007, Reproduction.
[101] A. Murdoch,et al. Estimating the risks of ovarian hyperstimulation syndrome (OHSS): implications for egg donation for research , 2007, Human fertility.
[102] M. Stefanini,et al. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles. , 2006, The Journal of endocrinology.
[103] H. Hashimoto,et al. New Insights into the Central PACAPergic System from the Phenotypes in PACAP‐ and PACAP Receptor‐Knockout Mice , 2006, Annals of the New York Academy of Sciences.
[104] J. Fahrenkrug,et al. Expression of pituitary adenylate cyclase activating peptide in the uterine cervix, lumbosacral dorsal root ganglia and spinal cord of rats during pregnancy , 2006, Peptides.
[105] L. L. Burger,et al. Pituitary Adenylate Cyclase Activating Polypeptide Messenger RNA in the Paraventricular Nucleus and Anterior Pituitary During the Rat Estrous Cycle1 , 2005, Biology of reproduction.
[106] J. Fahrenkrug,et al. Role of pituitary adenylate cyclase-activating peptide (PACAP) in the cyclic recruitment of immature follicles in the rat ovary , 2005, Regulatory Peptides.
[107] W. Gilbert,et al. Amniotic Fluid: Not Just Fetal Urine Anymore , 2005, Journal of Perinatology.
[108] G. Cho,et al. Expression of pituitary adenylate cyclase activating polypeptide and its type I receptor mRNAs in human placenta. , 2005, Journal of veterinary science.
[109] A. Arimura,et al. Effect of PACAP on LH release studied by cell immunoblot assay depends on the gender, on the time of day and in female rats on the day of the estrous cycle , 2004, Regulatory Peptides.
[110] M. Koppán,et al. Serotonin may alter the pattern of gonadotropin-induced progesterone release of human granulosa cells in superfusion system , 2004, Endocrine.
[111] J. Bockaert,et al. Impaired Somatodendritic Responses to Pituitary Adenylate Cyclase‐Activating Polypeptide (PACAP) of Supraoptic Neurones in PACAP type I ‐Receptor Deficient Mice , 2003, Journal of neuroendocrinology.
[112] Hyun Joon Kim,et al. Expression patterns of pituitary adenylate cyclase activating polypeptide and its type I receptor mRNAs in the rat placenta , 2003, Molecular reproduction and development.
[113] A. Arimura,et al. Neonatal PACAP administration in rats delays puberty through the influence of the LHRH neuronal system , 2002, Regulatory Peptides.
[114] H. Hashimoto,et al. Defects in reproductive functions in PACAP-deficient female mice , 2002, Regulatory Peptides.
[115] M. Stefanini,et al. Pituitary Adenylate Cyclase-Activating Polypeptide Modulates Plasminogen Activator Expression in Rat Granulosa Cell1 , 2002, Biology of reproduction.
[116] M. Koppán,et al. The effect of catecholamines, acetylcholine and histamine on progesterone release by human granulosa cells in a granulosa cell superfusion system , 2002, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[117] M. Koppán,et al. Influence of Melatonin on Basal and Gonadotropin-Stimulated Progesterone and Estradiol Secretion of Cultured Human Granulosa Cells and in the Superfused Granulosa Cell System , 2001, Gynecologic and Obstetric Investigation.
[118] M. Koppán,et al. Modulatory Effect of Acetylcholine on Gonadotropin-Stimulated Human Granulosa Cell Steroid Secretion , 2001, Gynecologic and Obstetric Investigation.
[119] Keesook Lee,et al. Stage-dependent regulation of ovarian pituitary adenylate cyclase-activating polypeptide mRNA levels by GnRH in cultured rat granulosa cells. , 2001, Endocrinology.
[120] H. Vaudry,et al. Pituitary adenylate cyclase‐activating polypeptide and its receptors in amphibians , 2001, Microscopy research and technique.
[121] F. Spencer,et al. Temporal relationships among uterine pituitary adenylate cyclase-activating polypeptide, decidual prolactin-related protein and progesterone receptor mRNAs expressions during decidualization and gestation in rats. , 2001, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.
[122] J. Bockaert,et al. PAC1 Null Females Display Decreased Fertility , 2000, Annals of the New York Academy of Sciences.
[123] I. Huhtaniemi,et al. Evidence That Pituitary Adenylate Cyclase-Activating Polypeptide Is a Potent Regulator of Fetal Rat Testicular Steroidogenesis1 , 2000, Biology of reproduction.
[124] C. Ha,et al. Central administration of an antisense oligodeoxynucleotide against type I pituitary adenylate cyclase-activating polypeptide receptor suppresses synthetic activities of LHRH-LH axis during the pubertal process. , 2000, Brain research. Molecular brain research.
[125] A. Arimura,et al. PACAP38 and PACAP27 administered intracerebroventricularly have an opposite effect on LH secretion , 2000, Peptides.
[126] E. Piccione,et al. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta. , 2000, Endocrinology.
[127] Y. Ueta,et al. Effects of Centrally Administered Pituitary Adenylate Cyclase-Activating Polypeptide on c-fos Gene Expression and Heteronuclear RNA for Vasopressin in Rat Paraventricular and Supraoptic Nuclei , 1999, Neuroendocrinology.
[128] W. Choi,et al. Gonadotropin stimulation of pituitary adenylate cyclase-activating polypeptide (PACAP) messenger ribonucleic acid in the rat ovary and the role of PACAP as a follicle survival factor. , 1999, Endocrinology.
[129] A. Arimura,et al. PACAP colocalizes with luteinizing and follicle-stimulating hormone immunoreactivities in the anterior lobe of the pituitary gland , 1998, Peptides.
[130] T. Kubo,et al. Rat Corpus Luteum Expresses Both PACAP and PACAP Type IA Receptor mRNAs , 1997, Peptides.
[131] A. Lanzone,et al. Control of human luteal steroidogenesis: role of growth hormone-releasing hormone, vasoactive intestinal peptide, and pituitary adenylate cyclase-activating peptide. , 1997, Fertility and sterility.
[132] T. Görcs,et al. New Aspects of the Neuroendocrine Role of PACAP a , 1996, Annals of the New York Academy of Sciences.
[133] J. Hannibal,et al. Transient periovulatory expression of pituitary adenylate cyclase activating peptide in rat ovarian cells. , 1996, Endocrinology.
[134] S. T. Anderson,et al. Pituitary adenylate cyclase-activating polypeptide acts within the medial basal hypothalamus to inhibit prolactin and luteinizing hormone secretion. , 1996, Endocrinology.
[135] B. Koch,et al. Evidence for the presence of receptors for pituitary adenylate cyclase-activating polypeptide in the neurohypophysis that are positively coupled to cyclic AMP formation and neurohypophyseal hormone secretion. , 1996, Neuroendocrinology.
[136] M. Magotti,et al. Effects of intravenously infused pituitary adenylate cyclase-activating polypeptide on adenohypophyseal Hormone secretion in normal men. , 1996, Neuroendocrinology.
[137] J. Hannibal,et al. Pituitary adenylate cyclase activating polypeptide (PACAP): occurrence and vasodilatory effect in the human uteroplacental unit , 1996, Regulatory Peptides.
[138] M. Palkovits,et al. Concentrations of pituitary adenylate cyclase activating polypeptide (PACAP) in human brain nuclei , 1995, Brain Research.
[139] M. Parada,et al. Dipsogenic effect of pituitary adenylate cyclase activating polypeptide (PACAP38) injected into the lateral hypothalamus , 1995, Brain Research.
[140] P. Chiodera,et al. Effects of intravenously infused pituitary adenylate cyclase‐activating polypeptide on arginine vasopressin and oxytocin secretion in man , 1995, Neuroreport.
[141] K. Sugita,et al. Central cardiovascular effects induced by intracisternal PACAP in dogs. , 1995, The American journal of physiology.
[142] Y. Zhong,et al. Pituitary adenylate cyclase-activating polypeptide stimulates steroidogenesis and adenosine 3',5'-monophosphate accumulation in cultured rat granulosa cells. , 1994, Endocrinology.
[143] G. Fink,et al. Pituitary adenylate cyclase-activating peptide-38 (PACAP)-38 is released into hypophysial portal blood in the normal male and female rat. , 1994, The Journal of endocrinology.
[144] J. Burrin,et al. PACAP-38 positively regulates glycoprotein hormone α-gene expression in placental cells , 1994, Molecular and Cellular Endocrinology.
[145] Y. Oiso,et al. Pituitary adenylate cyclase-activating polypeptide stimulates arginine vasopressin release in conscious rats. , 1993, Neuroendocrinology.
[146] M. Culler,et al. A novel hypothalamic peptide, pituitary adenylate cyclase activating peptide, modulates Sertoli cell function in vitro. , 1992, Biology of reproduction.
[147] E. Wallach,et al. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. , 1992, Fertility and sterility.
[148] H. Gowing,et al. Effects of a novel hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide, on pituitary hormone release in rats. , 1992, The Journal of endocrinology.
[149] M. Culler,et al. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. , 1989, Biochemical and biophysical research communications.
[150] OUP accepted manuscript , 2021, Human Reproduction.
[151] A. Tamas,et al. Protective effects of pituitary adenylate cyclase activating polypeptide against neurotoxic agents , 2018, Neurotoxicology.
[152] David Brink,et al. : A Review of the , 2018 .
[153] R. Canipari,et al. PACAP in the Reproductive System , 2016 .
[154] S. Kyo,et al. Role of PACAP and Its PACAP Type I Receptor in the Central Control of Reproductive Hormones , 2016 .
[155] A. Tamas,et al. PACAP as a Potential Biomarker: Alterations of PACAP Levels in Human Physiological and Pathological Conditions , 2016 .
[156] A. Tamas,et al. Occurrence and Functions of PACAP in the Placenta , 2016 .
[157] A. Tamas,et al. Examination of PACAP During Lactation , 2016 .
[158] Z. Rumbus,et al. The Role of PACAP in the Regulation of Body Temperature , 2016 .
[159] N. Amso,et al. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome. , 2011, The Cochrane database of systematic reviews.
[160] H. Tournaye,et al. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. , 2006, Fertility and sterility.
[161] S. Ochsner,et al. Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization. , 2002, Recent progress in hormone research.
[162] 野村 昌良. Effects of Centrally Administered Pituitary Adenylate Cyclase-Activating Polypeptide on c-fos Gene Expression and Heteronuclear RNA for Vasopressin in Rat Paraventricular and Supraoptic Nuclei , 2000 .
[163] M. Pesce,et al. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates adenylate cyclase and promotes proliferation of mouse primordial germ cells. , 1996, Development.